EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Unregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray-Market Access, and Emerging Public Health Risks

Kirubel T Hailu, Feven N Abriha, Yeabsera M Duguma, Ryan R Haddad, Tewodros Liyew, Alousious Kasagga

Cureus · 11.06.2026

DOI: 10.7759/cureus.110657 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cureus, erschienen am 11.06.2026. Verfasst von Kirubel T Hailu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Public Health, University College Cork, Cork, IRL. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Unregulated peptide use is emerging as a digitally mediated public health concern. Although peptide-based medicines have important therapeutic roles when developed, prescribed, manufactured, and monitored through regulated pathways, online biohacking and wellness spaces increasingly promote experimental or weakly evidenced peptides for fat loss, recovery, aesthetics, cognition, performance, and longevity. This narrative review examines how digital promotion, gray-market access, self-injection, stacking, informal titration, product-quality uncertainty, regulatory ambiguity, and weak pharmacovigilance interact to normalize poorly traceable peptide products outside clinical supervision. The central concern is not legitimate peptide medicine, but consumer experimentation with products of uncertain identity, purity, potency, sterility, and safety. Improved clinician awareness, adverse-event reporting, product-quality monitoring, digital risk communication, and proportionate regulatory oversight are needed to distinguish evidence-based peptide therapy from unregulated consumer use.

Schlagwörter

Stichwörter der Autor:innen

biohackingdigital health communicationspeptidespharmacovigilanceregulatory agenciesregulatory scienceself-experimentation

Autor:innen und Institutionen

  • Public Health, University College Cork, Cork, IRL.
  • Internal Medicine, Richmond University Medical Center, Staten Island, USA.
  • Medicine, Jimma University Medical School, Jimma, ETH.
  • Surgery, Kadisco General Hospital, Addis Ababa, ETH.
  • Clinical Research, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.
  • Public Health, Washington University in St. Louis, St. Louis, USA.

Zitieren

APA

Hailu, K. T., Abriha, F. N., Duguma, Y. M., Haddad, R. R., Liyew, T., & Kasagga, A. (2026). Unregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray-Market Access, and Emerging Public Health Risks. Cureus. https://doi.org/10.7759/cureus.110657

Vancouver

Hailu KT, Abriha FN, Duguma YM, Haddad RR, Liyew T, Kasagga A. Unregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray-Market Access, and Emerging Public Health Risks. Cureus. 2026. doi:10.7759/cureus.110657

BibTeX
@article{Hailu2026,
  author = {Hailu, Kirubel T and Abriha, Feven N and Duguma, Yeabsera M and Haddad, Ryan R and Liyew, Tewodros and Kasagga, Alousious},
  title = {Unregulated Peptide Use in the Age of Biohacking: Digital Promotion, Gray-Market Access, and Emerging Public Health Risks},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.110657}
}
Kostenlos starten →